Sangamo Therapeutics (SGMO) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Sangamo Therapeutics (OTC: SGMO) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.4 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Walmart will be lowering prices
- Stifel Starts SpaceX (SPCX) at Buy
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
